Beijing Boao Jingdian Biotechnology

Beijing Boao Jingdian Biotechnology, operating as CapitalBio Technology, is a leading Chinese provider of genetic testing and biochip technology solutions. The company integrates a complete industrial chain encompassing research and development, manufacturing, sales, and independent clinical laboratory services. Leveraging advanced biological detection technology, CapitalBio Technology develops comprehensive products for various applications, establishing itself as a pioneer and key developer in China's biochip industry.

The company emerged as an industrialization platform for Boao Biological Group Co., Ltd. and the Beijing National Engineering Research Center for Biochips, stemming from the life science expertise at Tsinghua University. This institutional foundation provided the core insight to translate cutting-edge academic research into practical applications, focusing on next-generation biological detection methods. This heritage underpins its role in formulating technical standards and holding a significant portfolio of related technology patents.

CapitalBio Technology serves diverse sectors including life science research, medical testing, new drug development, health management, and agriculture. Its mission is to consolidate its market-leading position in genetic testing and biochips while expanding into international markets. The company actively integrates modern and traditional medicine to offer health management and medical rehabilitation solutions, aiming to improve human health through its innovative products and services.